ProMIS Neurosciences: Funding, Investors & Team (Oct 2026)
ProMIS Neurosciences is a biotechnology company that focuses on finding and creating targeted treatments and diagnostic tools for neurodegenerative diseases like Alzheimer’s and ALS. The company, established in 2004, is based in Toronto, Canada.
ProMIS Neurosciences has raised $129M across 2 funding rounds on record, the most recent an undisclosed round of $6.7M announced in Jul 2025.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ProMIS Neurosciences Company Profile and Key Stats
Latest funding round on record: Jul 2025.
ProMIS Neurosciences Funding Rounds
ProMIS Neurosciences raised $123M in an undisclosed round announced in Jul 2024.
1 years later, an undisclosed round of $6.7M was announced in Jul 2025.
ProMIS Neurosciences Founders and Leadership Team
Contact details for the ProMIS Neurosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →ProMIS Neurosciences Funding Compared to Other Biotechnology Startups
ProMIS Neurosciences' latest round of $6.7M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ProMIS Neurosciences in Biotechnology and Toronto
Companies Similar to ProMIS Neurosciences
Tydra Labs is a biotechnology company that transforms crustacean shell waste into chitin and bio-products.
Medicenna is a clinical-stage immunotherapy company focused on oncology and the development and…
Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective…
Hemostemix Inc. is a Canadian biotechnology company that specializes in creating blood-derived cell therapies…
Avicanna is an organization in the biopharmaceutical sector that concentrates on enhancing medical cannabis…
Edesa Biotech is a privately-held company in the clinical stage that specializes in creating therapies for…
ME Therapeutics is a biotech company that specializes in finding and creating drugs for immuno-oncology that…
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and…
Medicus Pharma is a biotechnology research company that fast-tracks the progress of life sciences and…
ProteinQure is a biotechnology company specializing in creating innovative peptides for various medical…
Anodyne's mission is to create critical chemicals sustainably. Anodyne's approach takes advantage of nature's…
NervGen Pharma is a medicine company dedicated to creating solutions for the treatment of nerve damage and…
ProMIS Neurosciences Funding FAQs
What does ProMIS Neurosciences do?
ProMIS Neurosciences is a biotechnology company that focuses on finding and creating targeted treatments and diagnostic tools for neurodegenerative diseases like Alzheimer’s and ALS. The company, established in 2004, is based in Toronto, Canada.
How much funding has ProMIS Neurosciences raised?
ProMIS Neurosciences has raised $129M across 2 rounds on record. The most recent is an undisclosed round of $6.7M announced in Jul 2025.
When did ProMIS Neurosciences last raise funding?
ProMIS Neurosciences' most recent funding round on record is an undisclosed round of $6.7M, announced in Jul 2025.
Who founded ProMIS Neurosciences?
FundedIQ lists Neil Cashman (Founder) at ProMIS Neurosciences.
Where is ProMIS Neurosciences headquartered?
ProMIS Neurosciences is based in Toronto, Ontario, Canada.
How many employees does ProMIS Neurosciences have?
ProMIS Neurosciences is in the 11-50 employee band.
How does ProMIS Neurosciences' funding compare to other Biotechnology startups?
ProMIS Neurosciences' latest round of $6.7M is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's ProMIS Neurosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ProMIS Neurosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.